BioCentury | Aug 28, 2020
Distillery Therapeutics

Exon skipping therapy for Batten disease

...CLN3, in Phase I/II testing for Batten disease.Abeona Therapeutics Inc....
BioCentury | Jul 21, 2020
Emerging Company Profile

Hybrid CDMO-gene therapy developer Forge launches with $40M

...Miller stepped down in January as president and CSO of gene and cell therapy company Abeona Therapeutics Inc....
BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...will also serve as CEO. Former President and CEO Matthew Pauls stepped down in November. Abeona Therapeutics Inc....
...mitochondrial disease company as a scientist in 2016. Robin Sawka, BioCentury Staff Akcea Therapeutics Inc. ImCheck Therapeutics S.A.S. IsoPlexis Corp. Abeona Therapeutics Inc. Evaxion...
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...as its first chief commercial officer. Colao was EVP, CCO and head of BD at Abeona Therapeutics Inc....
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...workforce by about one third (see “Gene Therapy Holding Pattern” ). Rare genetic disease company Abeona Therapeutics Inc....
BioCentury | Dec 24, 2019
Financial News

Dec. 27 Financial Quick Takes: Cirius, Axsome, Abeona, Monopar, Paige.AI, Freeline

...71% (see “Axsome Continues Ascent” ). Abeona raises $103.5M in deal backed by Great Point Abeona Therapeutics Inc....
...B, Fabry disease and Gaucher disease (see “Syncona’s Sister Act” ). Elizabeth S. Eaton, Staff Writer Qiagen N.V. Abeona Therapeutics Inc. Cirius...
BioCentury | May 17, 2019
Product Development

Abeona tackles gene therapy’s problems in cystic fibrosis with chimeric AAVs

...would be to finally gain gene therapy a foothold in cystic fibrosis. On April 30, Abeona Therapeutics Inc....
...by PlasmaTech Biopharmaceuticals Inc. in 2015 and went public the same year under its new name Abeona Therapeutics Inc....
...infantile and juvenile Batten disease use the AAV9 vector as well. Companies and Institutions Mentioned Abeona Therapeutics Inc....
BioCentury | May 15, 2019
Company News

Management tracks: Biogen’s McKenzie departing for CSL; plus Rubius, SanBio, Avita and more

...as president, Europe and Darrel Cohen as head of clinical development. Thiel was CEO of Abeona Therapeutics Inc....
BioCentury | Mar 25, 2019
Company News

Thermo Fisher buying gene therapy manufacturer Brammer Bio

...Brammer Bio has announced partnerships with Sarepta Therapeutics Inc. (NASDAQ:SRPT), Voyager Therapeutics Inc. (NASDAQ:VYGR) and Abeona Therapeutics Inc....
BioCentury | Feb 12, 2019
Company News

Management tracks: Sanofi, Alexion, bluebird

...will become VP of finance and administration. Spota was CFO at Basilea Pharmaceutica AG (SIX:BSLN). Abeona Therapeutics Inc....
Items per page:
1 - 10 of 203
BioCentury | Aug 28, 2020
Distillery Therapeutics

Exon skipping therapy for Batten disease

...CLN3, in Phase I/II testing for Batten disease.Abeona Therapeutics Inc....
BioCentury | Jul 21, 2020
Emerging Company Profile

Hybrid CDMO-gene therapy developer Forge launches with $40M

...Miller stepped down in January as president and CSO of gene and cell therapy company Abeona Therapeutics Inc....
BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...will also serve as CEO. Former President and CEO Matthew Pauls stepped down in November. Abeona Therapeutics Inc....
...mitochondrial disease company as a scientist in 2016. Robin Sawka, BioCentury Staff Akcea Therapeutics Inc. ImCheck Therapeutics S.A.S. IsoPlexis Corp. Abeona Therapeutics Inc. Evaxion...
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...as its first chief commercial officer. Colao was EVP, CCO and head of BD at Abeona Therapeutics Inc....
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...workforce by about one third (see “Gene Therapy Holding Pattern” ). Rare genetic disease company Abeona Therapeutics Inc....
BioCentury | Dec 24, 2019
Financial News

Dec. 27 Financial Quick Takes: Cirius, Axsome, Abeona, Monopar, Paige.AI, Freeline

...71% (see “Axsome Continues Ascent” ). Abeona raises $103.5M in deal backed by Great Point Abeona Therapeutics Inc....
...B, Fabry disease and Gaucher disease (see “Syncona’s Sister Act” ). Elizabeth S. Eaton, Staff Writer Qiagen N.V. Abeona Therapeutics Inc. Cirius...
BioCentury | May 17, 2019
Product Development

Abeona tackles gene therapy’s problems in cystic fibrosis with chimeric AAVs

...would be to finally gain gene therapy a foothold in cystic fibrosis. On April 30, Abeona Therapeutics Inc....
...by PlasmaTech Biopharmaceuticals Inc. in 2015 and went public the same year under its new name Abeona Therapeutics Inc....
...infantile and juvenile Batten disease use the AAV9 vector as well. Companies and Institutions Mentioned Abeona Therapeutics Inc....
BioCentury | May 15, 2019
Company News

Management tracks: Biogen’s McKenzie departing for CSL; plus Rubius, SanBio, Avita and more

...as president, Europe and Darrel Cohen as head of clinical development. Thiel was CEO of Abeona Therapeutics Inc....
BioCentury | Mar 25, 2019
Company News

Thermo Fisher buying gene therapy manufacturer Brammer Bio

...Brammer Bio has announced partnerships with Sarepta Therapeutics Inc. (NASDAQ:SRPT), Voyager Therapeutics Inc. (NASDAQ:VYGR) and Abeona Therapeutics Inc....
BioCentury | Feb 12, 2019
Company News

Management tracks: Sanofi, Alexion, bluebird

...will become VP of finance and administration. Spota was CFO at Basilea Pharmaceutica AG (SIX:BSLN). Abeona Therapeutics Inc....
Items per page:
1 - 10 of 203